Skip to main content
HR 6106 117th Congress House Health Cardiovascular and respiratory health Civil actions and liability Drug safety, medical device, and laboratory regulation Emergency medical services and trauma care Immunology and vaccination Infectious and parasitic diseases Manufacturing

To amend title III of the Public Health Service Act to terminate the effective time period for immunity for manufacturers of COVID-19 vaccines, and for other purposes.

Introduced: December 1, 2021 Introduced by: Gooden, Lance Republican · Texas See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 2, 2021
Referred to the Subcommittee on Health.
Dec 1, 2021
Referred to the House Committee on Energy and Commerce.
Dec 1, 2021
Introduced in House
 Plain-English summary Congressional Research Service

This bill terminates on December 1, 2021, certain protections from liability that apply to manufacturers of COVID-19 vaccines. Currently, the liability protections generally expire on October 1, 2024, unless the underlying declaration of emergency is rescinded earlier.

What's happening now December 2, 2021

Referred to the Subcommittee on Health.

 Committees of jurisdiction 2
 Cosponsors 1
All 1 Republican 1